Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by BILLMINERon Nov 11, 2010 11:45pm

322 Views

Post# 17696685

Upside Potential

In my opinion there is very if any downside potential with Halo. open pitable base metal deposits are very valuable and Hudbay knows it. In optioning properties to Halo, I trust this mgmnt and the company is progressing and will increase shareholder value substantially. A buck cometh soon.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments